{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:21:22Z","timestamp":1785529282734,"version":"3.56.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Posttransplant mineral and bone diseases are causes of fractures, and their association with cardiovascular events is being studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We analyzed the evolution of biochemical, histological, and imaging parameters pre\u2013 and 1 y post\u2013renal transplantation in 69 patients and correlated mineral and bone findings with coronary calcifications. At inclusion and after 12 mo, clinical data and echocardiographic findings were recorded, and laboratory evaluations, radiography of the pelvis and hands, and bone biopsy were performed. Noncontrast cardiac computed tomography was performed during the second evaluation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Serum levels of fibroblast growth factor 23 and sclerostin decreased in all patients, parathyroid hormone levels decreased in 89.8% of patients, bone alkaline phosphatase levels decreased in 68.1% of patients, and alpha-Klotho levels increased in 65.2% of patients. More than half of the patients presented with renal osteodystrophy at both biopsies, but histological findings improved: a significant transition from high to normal or low turnover and no significant differences in volume, mineralization defect, or cortical porosity at the 2 evaluations. Alpha-Klotho, sclerostin, and bone alkaline phosphatase shifts affect bone changes. Neither echocardiographic findings nor vascular calcification scores differed between the 2 points. Both the pretransplant period (dialysis vintage, sclerostin, and low bone volume at baseline) and the maintenance of abnormalities in the posttransplant period (high turnover posttransplant) were the most reliable predictors of the severity of the coronary calcification percentile.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Renal transplantation improved bone and mineral abnormalities. The pretransplant period determines the severity of calcification.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004099","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T17:07:12Z","timestamp":1646932032000},"page":"e251-e261","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Improvement of Mineral and Bone Disorders After Renal Transplantation"],"prefix":"10.1097","volume":"106","author":[{"given":"Ana Carina","family":"Ferreira","sequence":"first","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."},{"name":"Nova Medical School, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mendes","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia","family":"Silva","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Cotovio","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Aires","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."},{"name":"Nova Medical School, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Caeiro","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00faben","family":"Ramos","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital de Santa Marta, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rute","family":"Salvador","sequence":"additional","affiliation":[{"name":"CEDOC, Tissue Repair and Inflammation Lab, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Correia","sequence":"additional","affiliation":[{"name":"CEDOC, Tissue Repair and Inflammation Lab, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Cabral","sequence":"additional","affiliation":[{"name":"CEDOC, Tissue Repair and Inflammation Lab, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Nolasco","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."},{"name":"Nova Medical School, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u00edbal","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal."},{"name":"Nova Medical School, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrneph.2009.192","article-title":"Bone disease after renal transplantation.","volume":"6","author":"Malluche","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00467-011-1829-6","article-title":"CKD-MBD after kidney transplantation.","volume":"26","author":"Wesseling-Perry","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-3046.2010.01405.x","article-title":"Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.","volume":"15","author":"Seeherunvong","year":"2011","journal-title":"Pediatr Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000362492","article-title":"Importance of vascular calcification in kidney transplant recipients.","volume":"39","author":"Cianciolo","year":"2014","journal-title":"Am J Nephrol"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2012.12.019","article-title":"Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients.","volume":"33","author":"Evenepoel","year":"2013","journal-title":"Semin Nephrol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/S0041-1345(00)01802-9","article-title":"Renal osteodystrophy: histologic evaluation after renal transplantation.","volume":"32","author":"Martins","year":"2000","journal-title":"Transplant Proc"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/ajkd.2000.8289","article-title":"Bone disease in patients with long-term renal transplantation and normal renal function.","volume":"36","author":"Carlini","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1046\/j.1523-1755.63.s85.31.x","article-title":"Bone disease in long-term adult kidney transplant patients with normal renal function.","author":"Montalban","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1046\/j.1523-1755.2003.00938.x","article-title":"The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.","volume":"63","author":"Rojas","year":"2003","journal-title":"Kidney Int"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0272-6386(04)00955-2","article-title":"Histologic evolution of bone disease 6 months after successful kidney transplantation.","volume":"44","author":"Cruz","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1590\/S0100-879X2006000100004","article-title":"Improvement of adynamic bone disease after renal transplantation.","volume":"39","author":"Abdallah","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.transproceed.2007.10.001","article-title":"Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients.","volume":"39","author":"Lehmann","year":"2007","journal-title":"Transplant Proc"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/j.1600-6143.2007.01950.x","article-title":"Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation.","volume":"7","author":"Borchhardt","year":"2007","journal-title":"Am J Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.kint.2016.10.008","article-title":"Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation.","volume":"91","author":"Evenepoel","year":"2017","journal-title":"Kidney Int"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1681\/ASN.2018060656","article-title":"A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation.","volume":"30","author":"Marques","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2215\/CJN.09950818","article-title":"Changes in bone histomorphometry after kidney transplantation.","volume":"14","author":"Keronen","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.ajkd.2012.07.022","article-title":"CKD-mineral and bone disorder management in kidney transplant recipients.","volume":"61","author":"Alshayeb","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"115689","DOI":"10.1016\/j.bone.2020.115689","article-title":"The role of static bone histomorphometry in diagnosing renal osteodystrophy.","volume":"142","author":"Salam","year":"2021","journal-title":"Bone"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee.","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bonr.2018.03.005","article-title":"Bone histomorphometry in the evaluation of osteomalacia.","volume":"8","author":"Bhan","year":"2018","journal-title":"Bone Rep"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/gfh217","article-title":"A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.","volume":"19","author":"Adragao","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography.","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"115460","DOI":"10.1016\/j.bone.2020.115460","article-title":"Quantitative histomorphometric analysis of halved iliac crest bone biopsies yield comparable ROD diagnosis as full 7.5\u2009mm wide samples.","volume":"138","author":"Novel-Catin","year":"2020","journal-title":"Bone"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ndt\/gfu291","article-title":"The demonstration of \u03b1Klotho deficiency in human chronic kidney disease with a novel synthetic antibody.","volume":"30","author":"Barker","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ckj\/sfz085","article-title":"Performance of soluble Klotho assays in clinical samples of kidney disease.","volume":"13","author":"Neyra","year":"2020","journal-title":"Clin Kidney J"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy.","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00467-020-04499-2","article-title":"Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race.","volume":"35","author":"Soeiro","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00223-020-00781-5","article-title":"The non-invasive diagnosis of bone disorders in CKD.","volume":"108","author":"Bover","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40620-017-0408-8","article-title":"Circulating markers of bone turnover.","volume":"30","author":"Vervloet","year":"2017","journal-title":"J Nephrol"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cca.2019.11.012","article-title":"Bone alkaline phosphatase: an important biomarker in chronic kidney disease\u2014mineral and bone disorder.","volume":"501","author":"Nizet","year":"2020","journal-title":"Clin Chim Acta"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/TP.0b013e3182985468","article-title":"Persistence of bone and mineral disorders 2 years after successful kidney transplantation.","volume":"96","author":"Neves","year":"2013","journal-title":"Transplantation"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00223-021-00910-8","article-title":"The role of bone volume, FGF23 and sclerostin in calcifications and mortality; a cohort study in CKD stage 5 patients.","volume":"110","author":"Ferreira","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00223-021-00837-0","article-title":"Bone mineral disease after kidney transplantation.","volume":"108","author":"Torregrosa","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders.","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/sdi.12415","article-title":"Sclerostin, osteocytes, and chronic kidney disease\u2014mineral bone disorder.","volume":"28","author":"Moys\u00e9s","year":"2015","journal-title":"Semin Dial"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1093\/ndt\/gft222","article-title":"Sclerostin in CKD-MBD: one more paradoxical bone protein?","volume":"28","author":"Jean","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/tri.13888","article-title":"Bone densitometry versus bone histomorphometry in renal transplanted patients: a cross-sectional study.","volume":"34","author":"Ferreira","year":"2021","journal-title":"Transpl Int"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00223-021-00838-z","article-title":"The role of bone biopsy in the management of CKD-MBD.","volume":"108","author":"Ferreira","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.18632\/aging.102297","article-title":"Fibroblast growth factor 23 expression in human calcified vascular tissues.","volume":"11","author":"Donate-Correa","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"e19595","DOI":"10.1371\/journal.pone.0019595","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells.","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ndt\/gfu301","article-title":"High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study.","volume":"30","author":"Drechsler","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/gft039","article-title":"Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?","volume":"28","author":"Viaene","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jc.2013-1521","article-title":"Sclerostin: another vascular calcification inhibitor?","volume":"98","author":"Claes","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1471-2369-15-190","article-title":"Serum sclerostin is an independent predictor of mortality in hemodialysis patients.","volume":"15","author":"Gon\u00e7alves","year":"2014","journal-title":"BMC Nephrol"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/ki.2015.194","article-title":"Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification.","volume":"88","author":"Qureshi","year":"2015","journal-title":"Kidney Int"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density.","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:08:23Z","timestamp":1749064103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004099","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,8]]}}}